Latest news
Loading news…
PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Investments
2
1 exits
Monthly Visits
Available in Pro Contacts
41
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- Valuation range
- $500M to $1B
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 7
- Active products
- 15
- IT spend
- $216K
Investor Activity
- Investments
- 2
- Portfolio orgs
- 2
- Exits
- 1
Company Info
- Org types
- company, investor
- HQ
- Redwood City, California, United States
Signals & Scores
- Trend (7d)
- -0.2
- Trend (30d)
- -0.8
- Trend (90d)
- 1.9
Investments by PMV Pharmaceuticals
Loading columns…
0 of 0Show
Page 1 / 1
Key People at PMV Pharmaceuticals
Co-Founder
Co-Founder, President & CEO
Chief Financial Officer
41
professional contacts at PMV Pharmaceuticals
Contact execs at PMV Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to PMV Pharmaceuticals
Loading news…
FAQs about PMV Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.